Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 24 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Kopran Ltd

About the Company - Kopran Ltd

Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 204.52 Cr. and Equity Capital is Rs. 48.21 Cr. for the Year ended 31/03/2022.
PharmaceuticalsParijat House, 1076, Dr. E. Moses Road, Mumbai Maharashtra
NamePosition Held
Mr. Susheel G SomaniChairman
Mr. Surendra SomaniExecutive Vice Chairman
Mr. Adarsh SomaniDirector
Mr. Varun SomaniDirector
Dr. Siddhan SubramanianIndependent Director
Dr. Sunita BanerjiIndependent Director
Mrs. Mamta BiyaniIndependent Director
Mr. Narayan AtalIndependent Director

Kopran Ltd. Share Price Update

Share PriceValue
Previous Day₹283.80

Basic Stock Data of Kopran Ltd

Market Cap 1,254 Cr.
Current Price 260
High / Low292/96.0
Stock P/E31.1
Book Value 91.6
Dividend Yield1.13 %
ROCE8.30 %
ROE6.29 %
Face Value 10.0

Data Source:

Kopran Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Operating Profit212119924272613101412623
OPM %18%19%14%12%19%21%18%10%9%9%8%5%15%
Other Income6453342100420
Profit before tax2321208232724106911418
Tax %27%26%26%24%25%25%27%24%23%24%26%23%25%
Net Profit17161561720188578314
EPS in Rs3.843.633.481.473.954.643.631.580.961.441.670.572.86

Kopran Ltd Quarterly Chart

Kopran Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit21344331303631464782875255
OPM %11%13%14%10%10%12%10%13%13%17%18%9%10%
Other Income622-4811193-0181137
Profit before tax51117-39112523322883823642
Tax %0%0%0%0%0%20%10%24%26%26%25%24%
Net Profit51117-39112020242162612732
EPS in Rs1.372.854.40-9.522.484.604.745.554.8614.2412.665.656.54
Dividend Payout %0%0%0%0%0%0%0%0%0%21%24%53%

Kopran Ltd Profit & Loss Yearly Chart

Kopran Ltd Growth

Compounded Sales Growth
10 Years:8%
5 Years:12%
3 Years:15%
Compounded Profit Growth
10 Years:9%
5 Years:6%
3 Years:8%
Stock Price CAGR
10 Years:28%
5 Years:49%
3 Years:33%
1 Year:134%
Return on Equity
10 Years:15%
5 Years:15%
3 Years:15%
Last Year:6%

Kopran Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital39393941434343434343484848
Preference Capital999990960000
Other Liabilities7072641229378909192128110135144
Total Liabilities250263299275264298315351370439611650678
Fixed Assets114109105102101104104113111112151165193
Other Assets116134174172160187201214229284425415422
Total Assets250263299275264298315351370439611650678

Kopran Ltd Reserves and Borrowings Chart

Kopran Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 3515346291626253160-3334
Cash from Investing Activity -10-9-9-10-9-18-11-25-13-25-84-13
Cash from Financing Activity -19-127-37-192-15-1-18-35123-20
Net Cash Flow6-70-00-0-0-00052

Kopran Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days7275689170867588948997108
Inventory Days1018710378119122138129154121202133
Days Payable120111691191159511890951048489
Cash Conversion Cycle5250101507411396127153106215152
Working Capital Days59741086780109121117126113200177
ROCE %8%12%14%14%14%19%14%16%14%30%21%8%

Kopran Ltd Financial Efficiency Indicators Chart

Kopran Ltd Share Holding Pattern

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
No. of Shareholders33,23635,83340,51238,19537,82239,90640,88341,76842,03441,56744,03853,791

Kopran Ltd Shareholding Pattern Chart

No. of Kopran Ltd Shareholders

Kopran Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Quant Healthcare Fund1010671.412.28
Motilal Oswal S&P BSE Healthcare ETF2510.070.01

Kopran Ltd ROCE Trend

Kopran Ltd EPS Trend

Kopran Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)5.6513.7714.244.865.55
Diluted EPS (Rs.)5.6513.7714.244.865.55
Cash EPS (Rs.)8.2914.9616.607.077.58
Book Value[Excl.RevalReserv]/Share (Rs.)91.1188.4056.6543.8638.95
Book Value[Incl.RevalReserv]/Share (Rs.)91.1188.4056.6543.8638.95
Revenue From Operations / Share (Rs.)114.2999.05113.7183.1282.75
PBDIT / Share (Rs.)11.3820.3323.0710.9411.42
PBIT / Share (Rs.)8.7418.0220.718.739.40
PBT / Share (Rs.)7.4816.9619.276.547.32
Net Profit / Share (Rs.)5.6512.6614.244.865.55
NP After MI And SOA / Share (Rs.)5.6512.6614.244.865.55
PBDIT Margin (%)9.9520.5220.2813.1613.80
PBIT Margin (%)7.6418.1918.2110.5011.35
PBT Margin (%)6.5417.1216.947.868.84
Net Profit Margin (%)4.9412.7812.525.846.71
NP After MI And SOA Margin (%)4.9412.7812.525.846.71
Return on Networth / Equity (%)6.1914.3225.1411.0814.25
Return on Capital Employeed (%)8.9118.9132.1416.3118.68
Return On Assets (%)4.199.9914.025.656.81
Long Term Debt / Equity (X)
Total Debt / Equity (X)
Asset Turnover Ratio (%)0.870.450.640.520.62
Current Ratio (X)2.252.741.721.591.54
Quick Ratio (X)1.521.751.100.950.99
Inventory Turnover Ratio (X)2.291.821.811.901.99
Dividend Payout Ratio (NP) (%)53.1010.6210.530.000.00
Dividend Payout Ratio (CP) (%)36.208.999.030.000.00
Earning Retention Ratio (%)46.9089.3889.470.000.00
Cash Earning Retention Ratio (%)63.8091.0190.970.000.00
Interest Coverage Ratio (X)9.0219.1515.995.315.49
Interest Coverage Ratio (Post Tax) (X)5.4812.9310.873.423.67
Enterprise Value (Cr.)595.141372.72511.32182.95265.52
EV / Net Operating Revenue (X)1.082.871.040.500.74
EV / EBITDA (X)10.8514.015.133.875.38
MarketCap / Net Operating Revenue (X)0.962.840.920.300.50
Retention Ratios (%)46.8989.3789.460.000.00
Price / BV (X)
Price / Net Operating Revenue (X)0.962.840.920.300.50

Kopran Ltd Profitability Ratios (%)

Kopran Ltd Liquidity Ratios

Kopran Ltd Liquidity Ratios (%)

Kopran Ltd Interest Coverage Ratios (%)

Kopran Ltd Valuation Ratios

Fair Value of Kopran Ltd Stock

Fair Value: ₹181.21

The stock is overvalued by 30.30% compared to the current price ₹260

*Investments are subject to market risks

Strength and Weakness of Kopran Ltd Stock

  1. The stock has a high average ROCE of 15.33%, which is a positive sign.
  2. The company has higher reserves (158.77 cr) compared to borrowings (4.62 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (370.31 cr) and profit (27.38 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 13.12 and average Dividend Yield of 13.18%.
  2. The stock has a high average Working Capital Days of 112.58, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 107.42, which may not be favorable.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Kopran Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE